Search - tctmd.com

Displaying 801 - 820 of 6629

Sort: Relevancy | Date

Presentation NY Valves 2024

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Presenter: Torsten P. Vahl

June 07, 2024

Presentation NY Valves 2024

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

Presenter: Omar K. Khalique

June 07, 2024

Presentation NY Valves 2024

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

Presenter: Saif Anwaruddin

June 07, 2024

Presentation NY Valves 2024

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

Presenter: Robert O. Bonow

June 07, 2024

Presentation NY Valves 2024

We Need More Data: Current and Future Research Directions

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

Device Selection and Procedural Technique: A Step-By-Step Guide

Presenter: Vinayak N. Bapat

June 07, 2024

Presentation NY Valves 2024

Practical Technique Considerations to Ensure Best Long-term Outcomes

Presenter: Kendra J. Grubb

June 07, 2024

Presentation NY Valves 2024

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Presenter: Joao L. Cavalcante

June 07, 2024

Presentation NY Valves 2024

Pathobiologic Insights From TAVR Explants

Presenter: Stephanie Sellers

June 07, 2024

Presentation NY Valves 2024

Surgical Explants for Failed TAVR: Frequency, Outcomes, and Clinical Implications

Presenter: Vinayak N. Bapat

June 07, 2024

Presentation NY Valves 2024

TAVR Durability: What Do We Know So Far?

Presenter: Helene Eltchaninoff

June 07, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

Left Main Coronary Artery Fluoroscopic Projection for Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve

Presenter: Julius Jelisejevas

June 07, 2024

Presentation NY Valves 2024

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

Access Disparities Affecting Appropriate AS Therapy

Presenter: David A. Wood

June 07, 2024

Presentation NY Valves 2024

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Presenter: Brian R. Lindman

June 07, 2024

Presentation NY Valves 2024

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Presenter: Michael J. Reardon

June 07, 2024

Presentation NY Valves 2024

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

Presenter: Robert L. Smith, Megan Coylewright

June 07, 2024

Presentation NY Valves 2024

CON: TMVR Has too Many Problems – Just Do M-TEER

Presenter: Saibal Kar

June 06, 2024

Advertisement

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

We Need More Data: Current and Future Research Directions

Device Selection and Procedural Technique: A Step-By-Step Guide

Practical Technique Considerations to Ensure Best Long-term Outcomes

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Pathobiologic Insights From TAVR Explants

Surgical Explants for Failed TAVR: Frequency, Outcomes, and Clinical Implications

TAVR Durability: What Do We Know So Far?

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Left Main Coronary Artery Fluoroscopic Projection for Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Access Disparities Affecting Appropriate AS Therapy

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

CON: TMVR Has too Many Problems – Just Do M-TEER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content